Cervical

ITTACc – ANZGOG’s latest cervical cancer study, incorporating ANZGOG’s first teletrial cluster!

A Phase II Trial of Tislelizumab in combination with Sitravatinib for Recurrent/Metastatic Cervical Cancer after Platinum-Based Chemotherapy. The ITTACc study is an ANZGOG-developed trial led in Australia by A/Prof Jeffrey Goh from the Royal [...]

ITTACc – ANZGOG’s latest cervical cancer study, incorporating ANZGOG’s first teletrial cluster!2023-10-18T11:49:12+11:00

Mother and daughter educating the doctors of tomorrow about gynaecological cancer

Jenny and her daughter Kathryn are both advocates for ANZGOG’s Survivors Teaching Students (STS) program in QLD, Australia and New Zealand respectively. “One of the first things I wanted to do when diagnosed was [...]

Mother and daughter educating the doctors of tomorrow about gynaecological cancer2023-10-18T12:03:47+11:00

Dr Jeffrey Goh explains ITTACc – ANZGOG’s latest cervical cancer study

ITTACc is ANZGOG’s phase II, randomised multi-centre non-comparative trial of sitravatinib in recurrent or metastatic cervical cancer that have progressed after standard therapies. ANZGOG spoke with ITTACc Principal Investigator, Dr Jeffrey Goh, who explained the study [...]

Dr Jeffrey Goh explains ITTACc – ANZGOG’s latest cervical cancer study2023-10-18T12:05:35+11:00

New Publication for the PHAEDRA study (PHAse 2 trial of DuRvalumab in Advanced Endometrial Cancer)  

A new journal has been published by the Journal for ImmunoTherapy of Cancer for ANZGOG's PHAEDRA study. The PHAEDRA study examined the activity of the immunotherapeutic agent durvalumab in women with advanced endometrial cancer that [...]

New Publication for the PHAEDRA study (PHAse 2 trial of DuRvalumab in Advanced Endometrial Cancer)  2021-07-22T23:34:55+10:00

ANZGOG’s OUTBACK Trial Among the Most Important Cervical Cancer Research Advances in the Past Year

A significant international study in cervical cancer treatment, the ANZGOG-led OUTBACK trial will be presented at the 2021 ASCO Annual Meeting Plenary Session to reveal its highly anticipated results. OUTBACK is an academic collaboration [...]

ANZGOG’s OUTBACK Trial Among the Most Important Cervical Cancer Research Advances in the Past Year2021-06-23T03:57:20+10:00

Assoc Prof Alison Brand AM speaks to ABC Radio about a recent New England Journal of Medicine paper

Assoc Prof Alison Brand AM spoke to Dr Norman Swan - the host of ABC Radio’s program Health Report - commenting on a recent paper in the New England Journal of Medicine about gene sequencing and [...]

Assoc Prof Alison Brand AM speaks to ABC Radio about a recent New England Journal of Medicine paper2021-03-01T05:08:29+11:00

Yvette shares her story with sarcomatous carcinoma, a rare cervical cancer

Yvette was diagnosed with sarcomatous carcinoma, a rare cervical cancer earlier in 2019. She is an advocate for cervical cancer awareness and calls for women to take responsibility for their health during National Cervical Cancer Awareness [...]

Yvette shares her story with sarcomatous carcinoma, a rare cervical cancer2021-02-10T04:23:35+11:00
Go to Top